Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Nevada | Bone graft & orthobiologics · California | |
|---|---|---|
| Surgeons, 2024 | 5 | 57 |
| Medicare fee-for-service cases | 186 | 2,787 |
| Growth since 2019 (Medicare FFS) | −18%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 150 in 2030 | 3,030 in 2030 |
| Forecast growth | −3.1%/yr to 2030 | +1.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.6 | 0.8 |
| Medicare Advantage share | 56% | 56% |
| Out of hospital | 0% (−1 pts since 2019) | 2% (+2 pts since 2019) |
| Cases per surgeon | 37 | 49 |
| Top 10 surgeons' share | 100% | 44% |
| Surgeons growing | 0 | 6 |
| New since the base year | 0 | 6 |
| Likely to stop billing it | 1 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $7,971 | $10K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.